来自MSN5 天
MRK's Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals
Merck MRK announced positive topline data from two pivotal phase III studies evaluating the investigational, once-daily, oral ...
HIV stigma can now be more dangerous than the virus—research shows how to address this
Speaking at the 16th International Aids Conference in 2006, the then UNAids executive director, Peter Piot, remarked: "Since ...
Healthline8 天
What Does a HIV Rash Look Like and How Is It Treated?
If you are HIV positive and experience a rash that isn’t relieved by over-the-counter drugs like hydrocortisone cream or diphenhydramine (Benadryl), see a healthcare professional who can ...
SCNow11 天
Know Your HIV Prevention Options
December is HIV/AIDS Awareness Month. It is a time to bring attention to HIV/AIDS, increase knowledge and awareness, and ...
Daily Monitor8 天
Uganda to get new HIV prevention drug
Uganda may obtain a new HIV prevention drug at a lower cost, a Ugandan scientist working on the drug has revealed. Lenacapavir, a long-acting injectable Anti-retroviral (ARV) drug for HIV ...
Nasdaq5 天
MRK's Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals
Merck MRK announced positive topline data from two pivotal ... new HIV infections and the first long-acting injectable HIV treatment medication administered twice yearly. In the past 60 days ...